Biomaterials Discovery
  

New Treatment for Horse Tendenitis and Desmitis

Dr Catrin Rutland, Assistant Professor of Anatomy and Developmental Genetics from the School of Veterinary Medicine and Science at the University of Nottingham, gave a fascinating talk on Tuesday 23rd January to the EPSRC Biomaterials Discovery programme grant and associated researchers.

 catrinrutland Catrin Rutland

Dr Catrin Rutland is involved in the development of a new treatment which she discussed, including the research paper, Gene Therapy Using Plasmid DNA Encoding Vascular Endothelial Growth Factor 164 and Fibroblast Growth Factor 2 Genes for the Treatment of Horse Tendinitis and Desmitis: Case Reports, which is available online at Frontiers in Veterinary Science.

 

Dr Catrin Rutland’s talk was part of a series of translational/clinical talks organised by the EPSRC Programme Grant in Next Generation Biomaterials Discovery, aimed to demonstrate the potential applications in the areas of Biomaterials Discovery. Speakers discuss key issues/challenges relating to their area of interest and discuss how new materials offer solutions.

Posted on Thursday 25th January 2018

Next Generation Biomaterials Discovery

Advanced Materials and Healthcare Technologies, School of Pharmacy, The University of Nottingham
University Park
Nottingham, NG7 2RD


telephone: +44 (0) 115 846 6246
email: BiomaterialsDiscovery@nottingham.ac.uk